Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$6.71 - $11.83 $15,204 - $26,806
-2,266 Reduced 81.69%
508 $3,000
Q2 2023

Aug 11, 2023

BUY
$11.12 - $22.2 $3,135 - $6,260
282 Added 11.32%
2,774 $31,000
Q1 2023

May 15, 2023

SELL
$18.7 - $23.07 $317 - $392
-17 Reduced 0.68%
2,492 $50,000
Q4 2022

Feb 10, 2023

BUY
$18.12 - $27.32 $4,638 - $6,993
256 Added 11.36%
2,509 $56,000
Q3 2022

Nov 10, 2022

BUY
$16.98 - $25.54 $25,249 - $37,977
1,487 Added 194.13%
2,253 $42,000
Q2 2022

Aug 12, 2022

SELL
$13.15 - $20.45 $16,726 - $26,012
-1,272 Reduced 62.41%
766 $14,000
Q1 2022

May 12, 2022

BUY
$14.54 - $21.5 $17,898 - $26,466
1,231 Added 152.54%
2,038 $36,000
Q4 2021

Feb 11, 2022

SELL
$20.24 - $36.01 $38,719 - $68,887
-1,913 Reduced 70.33%
807 $16,000
Q3 2021

Nov 05, 2021

BUY
$26.01 - $38.22 $59,250 - $87,065
2,278 Added 515.38%
2,720 $87,000
Q2 2021

Aug 06, 2021

BUY
$29.97 - $37.17 $1,288 - $1,598
43 Added 10.78%
442 $13,000
Q1 2021

May 07, 2021

SELL
$29.24 - $42.03 $614 - $882
-21 Reduced 5.0%
399 $13,000
Q4 2020

Feb 12, 2021

SELL
$35.35 - $50.67 $919 - $1,317
-26 Reduced 5.83%
420 $15,000
Q3 2020

Nov 06, 2020

BUY
$35.98 - $47.66 $16,047 - $21,256
446 New
446 $16,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.